Zhong C, Chen M, Wan B
Beijing Hospital, Beijing 100730, China.
Zhonghua Zhong Liu Za Zhi. 2001 Jan;23(1):64-6.
To evaluate the significance of serum prostate specific antigen (PSA), digital rectal examination (DRE), transrectal ultrasound (TRUS) and magnetic resonance imaging (MRI) as guide to perform prostate needle biopsy.
One hundred forty-eight patients suspicious of prostate neoplasm were undergone transrectal ultrasound-guided prostate needle biopsy. The pathologic diagnosis was analyzed in association with the results of PSA, DRE, TRUS and MRI in various combinations.
The positive rate of biopsy was 43.9%. While abnormal DRE or PSA contributed in the detection of prostate cancer, serum PSA became more reliable when combined with DRE, TRUS or MRI, but the contribution of each of the three diagnostic procedures was not significantly different. The sensitivity of MRI was higher than that of DRE or TRUS, whereas TRUS was more specific than PSA or MRI.
RE and PSA can be used for preliminary screening of prostate cancer. When combined with TRUS and MRI, the positive rate of diagnosis is increased. So is the specificity of the diagnosis which helps avoid unnecessary needle biopsy.
评估血清前列腺特异性抗原(PSA)、直肠指检(DRE)、经直肠超声(TRUS)及磁共振成像(MRI)作为前列腺穿刺活检指导手段的意义。
对148例疑似前列腺肿瘤患者进行经直肠超声引导下前列腺穿刺活检。结合PSA、DRE、TRUS及MRI的不同组合结果分析病理诊断情况。
活检阳性率为43.9%。虽然DRE或PSA异常有助于前列腺癌的检测,但血清PSA与DRE、TRUS或MRI联合时更可靠,不过这三种诊断方法各自的贡献无显著差异。MRI的敏感性高于DRE或TRUS,而TRUS比PSA或MRI更具特异性。
DRE和PSA可用于前列腺癌的初步筛查。与TRUS和MRI联合时,诊断阳性率提高,诊断特异性也提高,有助于避免不必要的穿刺活检。